Catalyst Pharmaceutical CPRX Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's operating lease liabilities (total)?
- Catalyst Pharmaceutical (CPRX) reported operating lease liabilities (total) of $2.68M in Q1 2026.
- How has Catalyst Pharmaceutical's operating lease liabilities (total) changed year-over-year?
- Catalyst Pharmaceutical's operating lease liabilities (total) decreased by 13.3% year-over-year, from $3.09M to $2.68M.
- What is the long-term trend for Catalyst Pharmaceutical's operating lease liabilities (total)?
- Over 5 years (2020 to 2025), Catalyst Pharmaceutical's operating lease liabilities (total) has grown at a 149.6% compound annual growth rate (CAGR), from $28.77K to $2.79M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.